Insulin, Regular, Human clinical trials
Also written human insulin, LY041001, Humulin R and Humulin.
Includes 6 studies of Isophane Insulin, Human.
How each study uses Insulin, Regular, Human is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Insulin, Regular, Human studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 28 Oct 1982 · HUMULIN R PEN · BLA 018780 (FDA, Drugs@FDA)
- European Union
- 21 Feb 1997 · Insuman · EMEA/H/C/000201 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Studies by the year they started
124 studies that test it; most in 2006 (18); 2 more planned to start later
| Year | Studies |
|---|---|
| 1999 | 4 |
| 2000 | 1 |
| 2002 | 6 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 7 |
| 2006 | 18 |
| 2007 | 11 |
| 2008 | 9 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 6 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 76 · Other 51
Mannkind Corporation (25) · Novo Nordisk A/S (19) · Eli Lilly and Company (10) · Biodel (5) · University Hospital Tuebingen (4) · Pfizer (4) · Halozyme Therapeutics (3) · University of Aarhus (3)
Often tested with
Tested in the same studies.
Insulin Aspart (9) · Insulin Glargine (6) · Insulin Lispro (5) · Metformin (3) · Glucose (3) · Insulin, Isophane (3) · Gliclazide (2) · Octreotide (2)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3, 1 in phase 3
Studies that test Insulin, Regular, Human, phase 3 first.
- Oct 2027Dose Response Study of Transdermal Human Insulin in PatientsPhase 2/3 · Transdermal Delivery Solutions Corp
- Mar 2027INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 DiabetesPhase 2 · Mannkind Corporation
- Nov 2027Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryPhase 2 · HealthPartners Institute
Studies
Open first, then newest update. How each study uses Insulin, Regular, Human is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 127
- Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryRecruitingPhase 2HealthPartners InstituteNCT07935278Written as Insulin (Humulin)
- Interplay of Central and Peripheral Vascular Effects of Insulin in ObesityNot yet recruitingEarly Phase 1University of Missouri-ColumbiaNCT07653464Written as human insulin
- Peripheral Vascular Effects of Insulin in ObesityNot yet recruitingEarly Phase 1University of Missouri-ColumbiaNCT07874945Written as human insulin
- INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 DiabetesRecruitingPhase 2Mannkind CorporationNCT07224321Written as Technosphere Insulin
- Intranasal Insulin for Postoperative Delirium in Older Patients With T2DMNot yet recruitingNot applicableWeidong MiNCT07720479Written as Insulin, human
- Dose Response Study of Transdermal Human Insulin in PatientsNot yet recruitingPhase 2/3Transdermal Delivery Solutions CorpNCT05159453Written as Human Insulin
- Human Models of Selective Insulin Resistance: Pancreatic ClampNot yet recruitingPhase 1Columbia UniversityNCT06558422Written as Insulin human
- Brain Insulin Resistance in Mood DisordersRecruitingPhase 1/2University Health Network, TorontoNCT03915613Written as Humulin R
- Topical Insulin Versus Irradiated Amniotic Fluid Gel for Wound Healing in Epidermolysis BullosaCompletedNot applicableTanta UniversityNCT07907523Written as Topical Insulin (Actrapid®)
- Insulin Intratympanic ApplicationCompletedEarly Phase 1Deraya UniversityNCT07535827Written as Insulin (Humulin)
- Topical Insulin for Ocular Surface Interface in Dry Eye DiseaseCompletedPhase 4Khyber Teaching HospitalNCT06939959Written as insulin human
- Effect of Topical Insulin on Healing Rate of Pemphigus LesionsCompletedPhase 2Alexandria UniversityNCT07461103Written as human insulin
- Pancreatic Clamp in NAFLDCompletedPhase 1Columbia UniversityNCT05724134Written as Insulin human
- Impact of Intranasal Insulin on Sympathetic Activity and Cerebral VasodilationSuspendedEarly Phase 1University of Missouri-ColumbiaNCT05153395Written as Human insulin
- HbA1c Variability in Type II DiabetesActive, not recruitingNot applicableWeill Cornell Medical College in QatarNCT02879409Written as human insulin
- Afrezza® INHALE-1 Study in PediatricsCompletedPhase 3Mannkind CorporationNCT04974528Written as Afrezza
- Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 DiabetesCompletedPhase 4Mannkind CorporationNCT05243628Written as Afrezza (insulin human) Inhalation Powder
- INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 DiabetesCompletedPhase 4Mannkind CorporationNCT05904743Written as Afrezza
- Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes PatientsCompletedPhase 3Model Clinical Research LLCNCT03324776Written as Afrezza Inhalant Product
- Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL)CompletedPhase 1Pennington Biomedical Research CenterNCT04739371Written as Insulin, Regular, Human
See all 127 studies that test Insulin, Regular, Human →
Given beside what is tested · 16 — Insulin, Regular, Human is usual care or a partner of the new treatment
- Dexamethasone/Pancreatic Clamp P&FWithdrawnPhase 1Columbia UniversityNCT06126354Written as Insulin human
- Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 DiabetesStatus unknownNot applicableNordsjaellands HospitalNCT05095259Written as insulin human
- Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac SurgeryCompletedPhase 4Emory UniversityNCT02556918Written as Regular Human Insulin
- Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00411892Written as inhaled human insulin
- Safety and Efficacy of Inhaled Insulin in Type 1 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00322257Written as inhaled human insulin
- Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20CompletedPhase 1Halozyme TherapeuticsNCT00803972Written as Insulin Human Injection
- Insulin in Total Parenteral NutritionCompletedPhase 4Fundación Pública Andaluza Progreso y SaludNCT02706119Written as Regular insulin added to TPN bag
- Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 DiabetesCompletedPhase 3Eli Lilly and CompanyNCT00437112Written as Human Insulin Inhalation Powder
- Sitagliptin in Non-Diabetic Patients Undergoing Cardiac SurgeryCompletedPhase 4Emory UniversityNCT02443402Written as Regular Human Insulin
- Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 InhalerTerminatedPhase 3Mannkind CorporationNCT01196104Written as Technosphere® Insulin Inhalation Powder
- Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes MellitusCompletedPhase 2Halozyme TherapeuticsNCT00883558Written as regular human insulin
- Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro AloneCompletedPhase 1Halozyme TherapeuticsNCT00862849Written as Regular Human Insulin
- A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy VolunteersCompletedPhase 1Mannkind CorporationNCT00674050Written as Technosphere Insulin (TI) Inhalation Powder
- A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmaticsCompletedPhase 1Mannkind CorporationNCT00673621Written as Technosphere Insulin Inhalation Powder
- A Study on the Effect of 2 Pen Devices on HbA1cCompletedPhase 4Eli Lilly and CompanyNCT00985712Written as Huminsulin Regular
- A Study for Patients With Type 1 Diabetes MellitusCompletedPhase 2/3Eli Lilly and CompanyNCT00447213Written as Human Insulin Inhalation Powder
As the comparator · 33 — what is tested is compared with Insulin, Regular, Human
- Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy SubjectsCompletedPhase 1Laboratorios Pisa S.A. de C.V.NCT07364669Written as Humulin® R (soluble human insulin, biosimilar)
- Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource SettingsCompletedPhase 4Jing LuoNCT05614089Written as NPH or premixed 70/30 (human insulin)
- Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human InsulinCompletedPhase 4Université NAZI BONINCT05768191Written as Humulin N plus Humulin R
- Insulin for Hyperglycemia in Stroke TrialCompletedPhase 4National Institute of Neurosciences and Hospital, DhakaNCT04834362Written as Human insulin
- A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes MellitusCompletedPhase 1AdociaNCT03916640Written as Humulin®
- A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat TissueCompletedPhase 1Eli Lilly and CompanyNCT02109029Written as Human Insulin
- A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes MellitusCompletedPhase 1AdociaNCT03512236Written as Symlin® and Humulin®
- Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 DiabetesTerminatedPhase 4Novo Nordisk A/SNCT01486966Written as human soluble insulin
- Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 DiabetesCompletedPhase 4Novo Nordisk A/SNCT01467401Written as biphasic human insulin
- Safety and Efficacy of Insulin Aspart in Children With Type 1 DiabetesCompletedPhase 4Novo Nordisk A/SNCT01467141Written as human insulin
- Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01486940Written as human soluble insulin
- Safety and Efficacy of Insulin Aspart in Subjects With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01707134Written as human soluble insulin
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01467323Written as biphasic human insulin
- Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic PatientsStatus unknownNot applicableFirst Affiliated Hospital, Sun Yat-Sen UniversityNCT02956655Written as Insulin intensive therapy: Human Insulin (Novolin-R, Novo Nordisk)
- Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.CompletedPhase 3BiodelNCT00849576Written as Regular Human Insulin
- Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 DiabetesCompletedPhase 2Novo Nordisk A/SNCT00698802Written as biphasic human insulin
- Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male VolunteersCompletedPhase 1Novo Nordisk A/SNCT01511159Written as insulin human
- Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in ParaguayCompletedPhase 4Universidad Nacional de AsunciónNCT02278913Written as Human Insulin
- A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human InsulinCompletedPhase 1Novo Nordisk A/SNCT02162407Written as human soluble insulin
- The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic PatientsStatus unknownPhase 4Taipei Veterans General Hospital, TaiwanNCT01270191Written as Humulin-N
Showing 20 of 33.
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered2
Codes
What other systems call Insulin, Regular, Human · ClinicalTrials.gg INT008951
- UNII (FDA) 1Y17CTI5SRINSULIN HUMANConfirmed FDA, Wikidata
- RxNorm 253182Confirmed FDA, Wikidata
- Wikidata Q50265665insulinConfirmed FDA, Wikidata
- NCI Thesaurus C65922Insulin HumanConfirmed FDA, Wikidata
- DrugBank DB00030One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 1Y17CTI5SR | INSULIN HUMAN | Confirmed FDA, Wikidata |
| RxNorm | 253182 | — | Confirmed FDA, Wikidata |
| Wikidata | Q50265665 | insulin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C65922 | Insulin Human | Confirmed FDA, Wikidata |
| DrugBank | DB00030 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.